300 related articles for article (PubMed ID: 14761204)
1. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
[TBL] [Abstract][Full Text] [Related]
2. Absolute and relative binding free energy calculations of the interaction of biotin and its analogs with streptavidin using molecular dynamics/free energy perturbation approaches.
Miyamoto S; Kollman PA
Proteins; 1993 Jul; 16(3):226-45. PubMed ID: 8346190
[TBL] [Abstract][Full Text] [Related]
3. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
[TBL] [Abstract][Full Text] [Related]
4. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
5. Rational automatic search method for stable docking models of protein and ligand.
Mizutani MY; Tomioka N; Itai A
J Mol Biol; 1994 Oct; 243(2):310-26. PubMed ID: 7932757
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
Chae K; Gibson MK; Korach KS
Mol Pharmacol; 1991 Nov; 40(5):806-11. PubMed ID: 1944245
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of binding sites for tamoxifen and tamoxifen derivatives in estrogen target and nontarget fetal organs of guinea pig.
Gulino A; Pasqualini JR
Cancer Res; 1982 May; 42(5):1913-21. PubMed ID: 7066903
[TBL] [Abstract][Full Text] [Related]
8. [Possible heterogeneity of cytoplasmic estrogen receptors].
Alekseeva ML; Minina LS; Novikov EA; Shchedrina RN; Fanchenko ND
Vopr Med Khim; 1984; 30(5):62-5. PubMed ID: 6528522
[TBL] [Abstract][Full Text] [Related]
9. Role of hepatic monooxygenases in generating estrogenic metabolites from methoxychlor and from its identified contaminants.
Bulger WH; Feil VJ; Kupfer D
Mol Pharmacol; 1985 Jan; 27(1):115-24. PubMed ID: 3965923
[TBL] [Abstract][Full Text] [Related]
10. [Accumulation of estrogen receptor complexes in the cell nuclei of the guinea pig uterus].
Novikov EA
Vopr Med Khim; 1985; 31(2):27-30. PubMed ID: 4002655
[TBL] [Abstract][Full Text] [Related]
11. Cytofluorometric analysis for estrogen receptors using fluorescent estrogen probes.
Kute TE; Linville C; Barrows G
Cytometry; 1983 Sep; 4(2):132-40. PubMed ID: 6685018
[TBL] [Abstract][Full Text] [Related]
12. [Binding of a series of estrogens to the estrogen receptor system of guinea pig hypothalamo-hypophyseal structures].
Shchedrina RN; Minina LS
Biull Eksp Biol Med; 1980 Oct; 90(10):478-80. PubMed ID: 7191732
[TBL] [Abstract][Full Text] [Related]
13. Computer design of bioactive molecules: a method for receptor-based de novo ligand design.
Moon JB; Howe WJ
Proteins; 1991; 11(4):314-28. PubMed ID: 1758885
[TBL] [Abstract][Full Text] [Related]
14. Quantitative molecular analysis predicts 5-hydroxytryptamine3 receptor binding affinity.
Schmidt AW; Peroutka SJ
Mol Pharmacol; 1990 Oct; 38(4):511-6. PubMed ID: 2233692
[TBL] [Abstract][Full Text] [Related]
15. Model assembly study of the ligand binding by p-hydroxybenzoate hydroxylase: correlation between the calculated binding energies and the experimental dissociation constants.
Peräkylä M; Pakkanen TA
Proteins; 1995 Jan; 21(1):22-9. PubMed ID: 7716166
[TBL] [Abstract][Full Text] [Related]
16. [Specificity characteristics of estrogen interaction with the cytoplasmic receptors of the uterus and oviducts in green monkeys (Cercopithecus griseus)].
Fanchenko ND; Alekseeva ML; Sturchak SV; Novikov EA
Vopr Med Khim; 1982; 28(4):56-8. PubMed ID: 7113055
[TBL] [Abstract][Full Text] [Related]
17. Estrogen-receptor binding and biologic activity of tamoxifen and its metabolites.
Wakeling AE; Slater SR
Cancer Treat Rep; 1980; 64(6-7):741-4. PubMed ID: 7427959
[TBL] [Abstract][Full Text] [Related]
18. Studies using fluorescent tetrahydrochrysene estrogens for in situ visualization of the estrogen receptor in living cells.
Miksicek RJ; Carlson KE; Hwang KJ; Katzenellenbogen JA
Mol Endocrinol; 1995 May; 9(5):592-604. PubMed ID: 7565806
[TBL] [Abstract][Full Text] [Related]
19. Computer simulation of the free energy of peptides with the local states method: analogues of gonadotropin releasing hormone in the random coil and stable states.
Meirovitch H; Koerber SC; Rivier JE; Hagler AT
Biopolymers; 1994 Jul; 34(7):815-39. PubMed ID: 8054467
[TBL] [Abstract][Full Text] [Related]
20. Benz[a]anthracene diols: predicted carcinogenicity and structure-estrogen receptor binding affinity relationships.
Anstead GM; Kym PR
Steroids; 1995 May; 60(5):383-94. PubMed ID: 7570711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]